Furthermore, compound 16 is degraded considerably more slowly in membrane preparations than Ang IV and stimulates proliferation of mouse neural stem cells at low concentrations, supporting a role of IRAP in neurogenesis ( Figure 5 Contrary to the results obtained after modification in the C-terminal of Ang IV where essentially all compounds examined exhibited some activity, oxidative cyclization of the side chains of Cys 1 and Cys 3 and consequently creation of an 11-membered disulfide macrocycle in the N-terminal rendered the inactive compound 20 (Figure 6)
Food and Drug Administration has classified BPC-157, GHK-Cu (for injectable routes of administration), and TB-500 (Thymosin 4 fragment) as Category 2 Bulk Drug Substancessubstances with safety concerns that are prohibited from being compounded by licensed pharmacies for human use
The primary difference is the stabilizing salt used
Research also suggests that these injections might decrease the risk of dementia and other cognitive impairments, especially in individuals with low B12 levels
Major classes of drugs currently in clinical trials include neuroprotectants, stem cell therapies, tau vaccines, humanized antibodies, metabolic modulators, neurotransmitter modulators, DNA modifications, anti-hypertensives, NSAIDs, and a host of various remedy and vitamin treatments [29]
Dadurch steht TB-500 fr eher systemische Forschungsanstze rund um Zellmigration und Angiogenese (Gefneubildung)
